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Flock House virus (FHV) is a (+) ssRNA virus that belongs to the Nodaviridae family. The 
viral genome is composed of two viral RNA’s: RNA 1 and RNA 2. Deletion and mutation 
studies in the N- and C-terminus of protein alpha have identified protein regions required 
for the packaging of FHV viral RNAs. Residues 2-31 on the N-terminus have been 
attributed with RNA2 recognition, while residues at positions 32-50 were required for the 
packaging of RNA1. The C-terminus is needed for packaging of both viral RNAs. The 
identified protein regions involved in packaging viral RNAs bind random cellular RNA with 
high affinity and standard methods of identifying RNA-protein interactions such as gel shift 
mobility assays will be unable to discriminate between specific and unspecific binding. Due 
to the difficulty in differentiating between specific and unspecific binding a new method for 
studying RNA-protein interactions was developed using a surface based detection approach. 
The surface based system monitors real-time binding, whereby specific and unspecific RNA-
protein interactions will be distinguished through comparison of relative association rates for 
each binding interaction. A well studied RNA-protein interaction, the HIV-1 Rev-RRE, was 
used to develop the methodology for the surface based system. 
 
Human immunodeficiency virus type 1 (HIV-1) encodes a regulatory protein Rev that binds 
to HIV-1 mRNA of the Rev responsive element (RRE). Rev-RRE interaction regulates viral 
gene expression by controlling the export of spliced and unspliced mRNAs into the 
cytoplasm. The high-affinity and specificity of the Rev-RRE binding has been well 
characterized and was used as a model system to gauge the sensitivity of the surface based 
detection system, which can be further used to characterize various RNA-protein 
interactions.  
 
The surface based system uses diffractive optics to detect real time binding of molecules to 
receptors that are immobilized on a flat sensor surface. An avidin coated sensor surface was 
applied to couple the small biotinylated Rev peptide to the surface followed by binding its 
 iii
complementary RRE RNA. The binding interactions of the 30 nucleotide RRE to the 
immobilized 23 residue Rev peptide were successfully monitored using the avidin sensor. 
The Rev-RRE interaction was heavily influenced by the immobilization technique and steric 
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Chapter 1: Introduction 
 
1.1 Viral Evolution  
 
Viruses are small infectious particles that act as intracellular parasites. They require an 
appropriate host for the production of new progeny virions. The evolution of viruses and the 
question of their origin has been a topic of debate for some time; viruses leave few remains 
and traces of their former progenitors during the course of their lifetime, and so their origin 
and evolution are difficult to track (1). Two main views exist on the emergence of viruses, 
the first one stating that viruses are cellular elements that have obtained the ability to self-
replicate and self-assemble. The second view suggests that viruses evolved in the prebiotic 
world prior to cellular organisms and are left over evidence of the hypothetical RNA world 
(1). Conclusive evidence supporting either theory does not exist, although studies of viral 
genomes and structure are providing insight as to which theory may fit best.  
 
The notion that viruses originated from cellular elements can be further broken down into 
two separate theories: the regressive and the cellular origin theories. The regressive theory 
suggests that viruses have devolved from intracellular parasites that have lost the ability to 
govern their own metabolic functions and only retained genes required to support their 
parasitic nature (1, 2). The regressive evolution theory is rejected predominantly for two 
reasons: because parasites derived from the three domains (Bacteria, Eukaryotes, Archaea) of 
life currently known, are still capable of producing their own proteins and energy and 
because no known intermediate states exist between cells and viruses. It has been proposed 
that the regressive theory could be applied to early RNA cells due to their simplicity 
compared to present-day cells. Early RNA cells living endosymbiotically in other RNA cells 
could have adopted a parasitic nature and lost key pathways for protein and energy 
production; the loss of specific metabolic pathways has been observed in existing parasites 
(2). The cellular origin theory explores the possibility of viruses arising from cellular genetic 
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fragments that have broken away from their normal function and established a parasitic 
lifestyle (1, 2).  It has been suggested that the cellular origin theory would be easier to defend 
if taken in the context of a pre-Last Universal Common Ancestor (LUCA) time. LUCA is 
considered to be the last link from which the three cellular domains have evolved. Early 
RNA cells in the pre-LUCA period were believed to contain segmented genomes, still 
observed in some RNA viruses, which would be more susceptible to becoming autonomous 
(2).  
 
The coevolution of viruses along with cells in a prebiotic world with the assistance of self-
replicating molecules is an integral part of the current view on viral evolution in a 
hypothetical RNA world.  The RNA world hypothesis suggests that RNA was present before 
DNA and proteins and was the first chemical system capable of supporting life. DNA and 
proteins evolved later and retained close interaction with RNA.(3) Early viruses employed 
RNA to store genetic information and used this primordial soup as a host system. Remnants 
of the RNA world can be observed through the study of viral structures.  Eukaryotic viruses 
such as the Polio virus contain 5’ untranslated regions (UTR) that have tRNA-like structures 
used in regulating translation; similar structures are seen at the 3’ UTR in plant virus 
genomes (3). Internal ribosome entry sites (IRES) are used by both viruses and cells that 
come from various organisms differing in complexity. IRES are approximately 180 
nucleotides long and form triple pseudoknot RNA structures involved in translation 
initiation. IRES maintain high efficiency and take the place of proteins that act as translation 
initiation factors (3). There are no methods that can test any of the views on viral evolution, 
although some insight can be gained by studying new emerging strains of viruses whose 
lineage can be directly traced, such as new strains of the Influenza virus and emerging 
coronaviruses (SARS-CoV).  
 
Viruses have been in existence for some considerable time as they have diverse hosts ranging 
from plants to insects to higher animals. The rapid evolution of viruses is attributed to the 
rate at which viral genomes acquire mutations (0.1-1% per year), leading to many divergent 
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classes of viruses (4). RNA genomes have a higher mutation rate than DNA genomes; during 
replication misinsertion errors have been estimated to be in the range of 10-3 to 10-5 
substitutions per nucleotide per round of copying. The higher mutation rates in RNA viral 
genomes have been attributed to reverse transcriptase’s and RNA polymerase’s lack of 
proofreading domains (5). The classical classification system for new emerging viruses used 
primarily four delineating characteristics: the nature of the genome (DNA or RNA), the 
capsid symmetry, the presence of an envelope, and the dimension of the virion. Rapid 
development of sequencing methods has enabled complete nucleotide sequences of viral 
genomes to be acquired, and comparison of these genomes has led to the discovery of 
similarities between viruses that had previously been thought of as unrelated (4). Similarities 
discovered in viral genomes led to the grouping of viruses into superfamilies according to 
their genome organization. Viruses that infect different hosts (plants, animals, and insects) 
were found to contain many similar features in their genome belonging to different families, 
suggesting that these viruses evolved from a common ancestor (4). The Flaviviridae family of 
viruses is one example of viruses whose genome exhibits features similar to other viral 
families.  The genomes of Flaviviridae viruses lack 3’ end poly-(A) tails, usually observed in 
negative-strand RNA viruses.  Instead of 3’ poly-(A) tail a stable stem-and-loop structure 
exists, a feature seen in plant viruses. Replication and translational machinery in Flaviviridae 
viruses is organization in a similar manner as in picornaviruses (4). The variation in genome 
makeup of the Flaviviridae family supports the theory that viruses have evolved from a 
common ancestor. 
 
RNA viruses are the most abundant group of viruses that span all kingdoms. RNA viruses are 
more adaptable than DNA viruses due to the plasticity of their genomes (5). There is a 
consistent need for new vaccines and antivirals to combat existing and emerging viruses; only 
very few viruses can be permanently controlled by either before further mutation occurs. 
Creating effective methods to control viruses requires an understanding of viral mechanism 
structures and how they function.  
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1.2 Research Scope 
 
Viral RNA packaging is as yet imperfectly understood, specifically how the viral RNA is 
preferentially packaged over cellular RNA. Specific RNA sequences that interact with viral 
coat proteins during packaging have only been identified for a very few viruses by gel shift 
mobility experiments. Standard methods used for studying RNA-protein interactions cannot 
distinguish very well between specific and unspecific RNA binding. A novel method is 
applied to study RNA-protein interactions in positive single-stranded RNA ((+) ssRNA) 
viruses, using a surface based detection system. Method development with the dotLab, a 
surface based detection system is explored in Chapter 2 with the Rev-RRE system. 
Identification of RNA sequences in the Flock House virus (FHV) involved in packaging is 
discussed in Chapter 3. 
  
1.3 The Axela dotLab System 
 
The dotLab system (Axela) uses diffractive optics to detect changes on the surface of sensor 
chips. The configuration and function are very similar to those of surface plasmon resonance 
instruments. Unlike surface plasmon resonance, which uses a thin metal film excited by light 
to produce an oscillating wave of surface charge density (plasmon resonance), the dotLab 
system uses optical diffraction to detect changes on the sensor surface (6, 7). A bare sensor 
surface will not increase the diffraction signal intensity because no there is no change in the 
surface pattern, although upon binding a molecule of interest, the height of the sensor 
surface is increased and becomes patterned. These changes in turn alter the diffraction 
pattern due to the constructive and destructive interferences of light and produce a 
measurable signal recorded as diffractive index (DI) (7). Applications of the dotLab system 
are discussed in Chapter 2 and 3. 








Human immunodeficiency virus type-1 (HIV-1) is a member of the Retroviridae family, 
part of the Lentivirus genus. HIV-1 contains a (+) ssRNA genome made up of two identical 
RNA strands joined at their 5’ ends (8). The viral genome encodes four primary genes found 
among all retroviruses: gag encodes the necessary structural proteins required for capsid 
formation; pro, a protease, is required for processing capsid polypeptides; pol contains 
genetic information for reverse transcriptase, RNase H, and integrase functions; env 
produces envelope glycoproteins. Reverse transcriptase is an enzyme unique to the 
Retroviridae family and is responsible for converting the (+) ssRNA to double strand DNA 
(dsDNA) upon viral infection. RNase H plays an important role during reverse transcription 
by destroying the RNA template. The integrase activity is responsible for inserting the 
dsDNA into the host chromosome (8). HIV-1 also encodes many regulatory proteins that 
aid it in its lifecycle.  
 
Regulatory proteins are translated from different mRNA splice variants and are found 
surrounding the env gene on the HIV-1 genome. The regulatory genes encoding regulatory 
proteins are tat, rev, nef, vif, vpr, and vpu (Figure 2.1) (8, 9). Tat protein initiates replication 
by binding to a 60 nucleotide stem-loop region, known as the trans-activating response 
region (TAR), at the 5’ end of HIV-1 RNA (9). Negative factor (Nef) has been shown to 
downregulate cell surface receptor production important in eliciting a host immune 
response, thereby increasing HIV-1 virulence (10, 11). During reverse transcription, Nef was 
found to increase dsDNA production (12). Rev coordinates the transport of unspliced and 
partially-spliced mRNAs from the nucleus to the cytoplasm, by binding the Rev responsive 
element (RRE) RNA (13). Vif, vpr, and vpu assist the virus in viral transmission among cells, 
replication, and virion assembly and release (9). HIV-1 has been extensively studied and 
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Figure 2.1- HIV-1 genome organization. 
 
 
2.2 Rev-RRE Structure and Function in HIV-1 
 
RNA-protein interactions between Rev protein and its RRE RNA counterpart function to 
transport unspliced mRNAs from the nucleus into the cytoplasm. Once the viral RNA has 
been reverse transcribed into dsDNA and integrated into a cell’s chromosome by integrase, 
the integrated DNA is referred to as proviral DNA, and may begin transcribing. HIV-1 
produces only a single RNA transcript to fill numerous roles: it serves as a template for 
structural proteins; its further processing allows for production of many regulatory proteins; 
and it is required for formation of new progeny through encapsidation. With cellular RNAs, 
only fully spliced mRNA containing no introns is allowed to cross the nuclear pore complex 
(NPC) into the cytoplasm (14). In contrast, HIV-1 transports full length genomic RNAs 
and partially spliced RNAs into the cytoplasm; HIV-1 achieves this with the Rev protein and 
RRE RNA interaction.    
 
Rev is a 116 amino acid protein with two active domains and the capability to form 
oligomers. The N-terminal domain contains the arginine rich nuclear localization signal 
(NLS) enabling Rev to be transported into the nucleus through the NPC. The NLS overlaps 
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with the RRE binding site; the close proximity of the two signals is believed to prevent Rev 
from transporting the mRNA back to the nucleus. While Rev is bound to the RRE signal, 
the NLS signal is effectively blocked (15, 16). The C-terminal end has the nuclear export 
signal (NES), and any mutations in this region negate the transport of Rev into the 
cytoplasm (17-19). Residues 34-50 were shown to contain the essential binding site required 
for the Rev-RRE interaction (20). A 23 amino acid Rev peptide has been used to study 
RNA-protein interaction using NMR.  
 
The high affinity binding site for Rev is the RRE RNA element located on the env gene (21). 
The high binding specificity of RRE towards Rev is due to its specific secondary structure. 
The full RRE is 351 nucleotides (nt) long, and the high affinity binding site was pinpointed 
to nucleotides 103-111 and 123-133 on stem region IIB and IID (22, 23). The binding site 
structure contains a 10-base internal loop surrounded by stems. Rev was shown to bind in 
the major groove in close proximity to the internal loop of the RRE. Upon Rev binding, a 
GG base pair undergoes a structural change with the ribose of one base flipping from a syn 
to an anti conformation (24, 25). The conformational change, results in a widened major 
groove allowing arginine and asparagine side chains to interact with specific base pairs 







Figure 2.2- Rev-RRE high affinity binding sites. 
 
 
2.3 Rev-RRE Role in Nuclear Transport 
 
The full-length HIV-1 genome is ~9 kb, and singly spliced mRNA is ~4 kb. Both contain 
introns and require Rev/RRE in order to be transported into the cytoplasm for structural 
protein production. Fully spliced mRNAs are able to cross into the cytoplasm using a cell’s 
export pathway and are ~2 kb each coding for Tat, Nef, and Rev (13). The transport of 
molecules from the nucleus involves NPCs, gated structures made up of many proteins called 
nucleoporins. Nucleoporins interact with many different transport receptor proteins to carry 
molecules across the nucleus membrane (14). Cofactors involved in the cell’s transport of 
molecules from the nucleus have been identified as facilitating Rev in RNA transport.   
 
Immediately after HIV-1 has infected a cell and has produced its proviral DNA, the amount 
of regulatory proteins is low; the majority of the transcribed viral genome is fully spliced and 
exported into the cytoplasm for translation. As Rev is being produced, it is transported into 
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the nucleus. Rev has been found to bind to importin-β, which is normally known to interact 
with importin-α to transport molecules into the nucleus (16, 27).  However, the arginine-
rich NLS present in Rev is very similar to the binding domain of importin-α known to 
interact with importin-β. It has since been suggested that Rev and importin-β interact 
directly in the absence of importin-α (28, 29). Accumulation of Rev inside the nucleus 
allows binding to stems IIB and IID of RRE, recruiting multiple Rev proteins to bind to a 
single RNA. The formation of oligomers by Rev is necessary for RNA transport to occur as it 
has been observed that a single Rev molecule is incapable of transporting RNA alone (30). 
The RRE-bound Rev interacts with its NES and exportin-1 for export of RNA into the 
cytoplasm (31). Exportin-1 is a member of the importin-β family of receptors and was 
previously known as CRM-1 (the chromosome region maintenance gene 1) (32, 33). The 
importin-β family of proteins interacts with Ran-GTP/GDP, which, through GTP 
hydrolysis, provides energy for the transport. Other cofactors are: eIF-5A, Rip/Rab 
(nucleoporin-like proteins), and RNA helicase A have been found to interact with the Rev-
RRE system, although their precise roles have yet to be investigated (34-36).       
 
2.4 Research Objective 
 
Rev-RRE has been chosen for its high binding specificity and affinity in vitro. A portion of 
Rev and RRE containing the minimum binding sites required for their interactions will be 
used with the dotLab system to monitor the binding. The Rev-RRE have a tight interaction 
with a Kd of 0.2 nM (37).        
 
The Rev peptide will have a biotin group attached to its N-terminus and will be bound to 
the sensor surface via the streptavidin-biotin interaction. The RRE RNA will be washed over 
the sensor surface once the binding of Rev has occurred. The aim of the study is to 
successfully monitor the real-time binding of RRE to the immobilized Rev peptide, from 
which the kinetic data may be extracted. The dotLab system is primarily used for the study 
of larger molecules, and the main goal of this study is to test whether its application can be 
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extend to smaller molecules. The use of the dotLab system will then be applied to a novel 
virus, the Flock House virus, to aid in the identification of RNA sequences involved in 
genome packaging, discussed further in Chapter 3. A truncated Rev (23 residues) and RRE 
(30 nucleotides) containing the high affinity binding sites will be used to test the sensitivity 
of the dotLab system (Figure 2.3). The RRE RNA has been modified for stability, without 
affecting binding efficiency, and has been used in previous NMR studies; two extra bases 
were added on stem IID, and the hairpin loop was changed to a more stable UUCG 
tetraloop.  The Rev peptide contains a highly positive overall charge and is able to bind many 
RNA molecules unspecifically, by measuring the relative association rates (kON) with the 
dotLab system; specific binding to the RRE RNA should be visible in the kON rates 





Figure 2.3- Minimum high affinity binding and specificity regions used in the binding study.  







2.5 Materials and Methods 
 
2.5.1 Minimization of RNase Contamination 
 
A number of precautions were taken to minimize RNase contamination during RNA 
production. Fresh gloves were worn at all times. All preparation areas were wiped with 
RNase AWAYTM. All buffers were made from nuclease-free Milli-Q water and autoclaved. 
All the labware used was wrapped in aluminum foil and autoclaved at 121 °C; prior to use, it 
was washed with RNase AWAYTM followed by rinsing 3X with nuclease-free Milli-Q water. 
All plastic-ware utilized was RNase free certified by their respective manufacturers. During 
RNA synthesis reactions RNase inhibitor was added. 
 
2.5.2 RNA Template Preparation  
 
The DNA template was prepared by combining the bottom strand with the top strand 
DNA. The bottom strand contains the DNA sequence that will serve as the template for 
RNA synthesis and has the complimentary sequence for the top strand T7 promoter. The 
top strand is an 18 bp primer that anneals to the promoter region of the bottom strand 
creating T7 enzyme binding site.  
 
The top strand (5’TAATACGACTCACTATAG 3’) and bottom strand 
(5’GGTGTACCGTCAGCCGAAGCTGCGCCCACCTATAGTGAGTCGTATTA 3’) 
DNA oligos were obtained from Sigma Aldrich. Lyophilized pellets of each strand are 
resuspended in nuclease free water (nf. water) to make a 100 μM solution. A 20 μM 
template solution (20 μM bottom strand, 30 μM top strand, 10 mM Tris pH 8.0, and 10 
mM MgCl2 final concentration) is prepared by heating at 95 °C for 5 minutes and chilling 
on ice for 5 minutes.          
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2.5.3 Synthesis of RNA 
 
RNA synthesis was performed with the prepared template using the T7 RNA polymerase by 
means of a runoff transcription. The transcription reaction mixture was set up as described in 
Table 2.1.  
 
Table 2.1- Transcription reaction mixture. 
Solution Final Concentration 
HEPES buffer pH 7.5 80 mM 
DTT  15 mM 
MgCl2 33 mM 
Spermidine 1 mM 
rATP, rGTP, rCTP, rUTP 3.75 mM each 
20 μM Template  0.5 μM 
RNase Inhibitor 1 unit/μL 
T7 RNA polymerase  
 
 
After the addition of T7 RNA polymerase enzyme the reaction is incubated in a water bath 
at 37 °C for a total of 6 hours. Once 3 hours have passed half the amount of T7 enzyme and 
MgCl2 are added. Once 6 hours have passed a white precipitate of magnesium 
pyrophosphate should be observed. The reaction is spun at maximum speed to pellet the 
magnesium pyrophosphate. The transcription reaction is transferred to a new container and 
0.5 M EDTA is added to sequester any remaining magnesium.   
 
The transcription reaction is ethanol precipitated with the addition of 1/10th the volume of 3 
M sodium acetate (pH 5.2) and 2.5 times the volume of cold 100% ethanol. The 
precipitation reaction is left at -80 °C for an hour or 10 minutes on dry ice, followed by 
centrifugation at maximum speed (4 °C) to pellet the precipitant. The pellet is washed with 
the total volume of the precipitation using cold 70% ethanol to remove excess salt. The 
pellet is centrifuged at maximum speed (4 °C). The supernatant is removed and the 
remaining pellet is placed on dry ice for 10 min. to freeze before placing on the FreeZone 
Plus 4.5L console system lyophilizer (Labconco) to dry.       
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2.5.4 RNA Purification  
 
The RNA produced by in vitro transcription is purified using polyarcylamide gel 
electrophoresis (PAGE). The dried RNA pellet is resuspended in 8 M urea and run on a 
12% denaturing polyacrylamide gel containing urea as the denaturant. The transcription 
reaction is separated on a 14x15 cm gel with the Hoefer SE 400 electrophoresis unit. The 
RNA resuspended in urea is loaded onto the gel and a separate well is loaded with 
bromophenol blue and xylene cyanol dyes to monitor the progress of the gel. The gel is 
finished and may be stopped once the bromophenol blue dye band has almost run off. The 
RNA transcript product will appear in between the two dye bands and can be visualized by 
UV shadowing on a silica gel sheet.        
 
The crush and soak method is used to purify the RNA from the gel and the transcription 
mixture. The RNA band is cut out of the polyacrylamide gel and the gel piece is cut into 
small pieces. The gel pieces are placed in a 15 ml falcon tube with enough TEN buffer (10 
mM Tris pH 7.6, 1 mM EDTA and 0.3 M NaCl) to cover all the gel fragments. The falcon 
tube is incubated at 65 °C for 10 min. and left shaking for 2 hours to overnight. After the 
crush and soak, the tubes are spun at maximum speed and the supernatant is carefully 
transferred to a new tube avoiding transfer of any polyacrylamide. The RNA is ethanol 
precipitated from the supernatant and resuspended in water.  
 
The purification of the RNA is confirmed on a 12% denaturing polyacrylamide gel stained 
with 1X SYBR Green II dye. The gel was visualized by excitation at 302 nm with a 537 nm 
emission filter on the FluoroChem FC2 imaging illuminator coupled with AlphaEaseFC 
v.6.0 software (Alpha Innotech)  The RNA concentration was determined using the 





2.5.5 Purification of Rev Peptide 
 
Crude synthesis of the 23 amino acid Rev (DTRQARRNRRRRWRERQRAAAAR) peptide 
was obtained from CanPeptide Inc.. 10 mg of the crude peptide were dissolved in 5 mL of 
nf. water with 10% acetonitrile. The solution was spun at 13 000 rpm for 30 minutes, before 
injecting into an HPLC system. The peptide was purified by reverse phase high pressure 
liquid chromatography (RP-HPLC) on a Waters HPLC system. Vydac C18 column (5 μm 
300Å, 4.6x100mm) (Grace) was used for purification and elution was achieved with a linear 
gradient from 10 to 60% of solvent B (100% acetonitrile 0.04% TFA) in solvent A (0.1% 
TFA) over 40 minutes at 1 mL/min flow rate. Absorbances were monitored at 220 nm and 
280 nm with the Waters 2996 photodiode array detector. The solvents used for the HPLC 
were filtered using a 0.2 μm membrane filter and degassed. The Rev fraction collected was 
characterized by electrospray ionization mass spectrometry (ESI-MS). The sample was 
prepared for ESI-MS by diluting it with a solution containing 1:1 acetonitrile:water with 
0.2% formic acid. Once correctly characterized the HPLC fraction was lyophilized and 
resuspended in nf. water.  
 
The concentration of the recovered peptide is determined using the NanoDrop UV-Visible 
spectrophotometer (NanoDrop Technologies). The extinction coefficient for the 23 amino 
acid Rev peptide was determined using the ProtParam tool on the ExPASy (Expert Protein 
Analysis System) proteomics server of the Swiss Institute of Bioinformatics (38).  
 
2.5.6 Labeling and Purification of Rev Peptide  
 
The labeling reaction was set up with 1:5 molar ratio of peptide to biotin as was determined 
by Selo, I. et al. for preferential biotinylation of N-terminal amino groups in peptides. The 
biotin N-hydroxysuccinimide ester (BNHS) (Sigma Aldrich) was dissolved in dry 
dimethylformamide. The reaction mixture contained 70 nmoles of Rev peptide in 120 μL 
phosphate buffer (50mM, pH 6.5) followed by the addition of 350 nmoles of BNHS (9.5 
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μL). The final concentration of organic solvent should be below 20% in the reaction 
mixture. The reaction was left at 4 °C for one hour and stopped by acidification with 70 μL 
of 1% trifluoroacetic acid (TFA). The reaction was qualitatively checked by ESI-MS for the 
correct product formation before purification. Purification of the biotinylated Rev peptide 
was performed in the same manner as the purification of the crude synthesis and the 
concentration was determined on the NanoDrop UV-Visible spectrophotometer (NanoDrop 
Technologies).           
 
2.5.7 Rev-RRE Binding Assay  
 
The Rev-RRE binding assay was performed and monitored on the dotLab system (Axela 
Inc.). The dotLab system software version 1.0.12.15 was used to write the methods that 
would be executed by the instrument. A general procedure used to load the samples onto the 
sensors is outlined in Figure 2.4. The dotLab sensors already contain avidin covalently 
attached to the surface. The sensors were taken from the 4 °C storage and were allowed to 
come to room temperature (~1 hour) before use. All the washing steps in the method were 
performed with the 1X phosphate buffered saline (PBS) solution (137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7). The 1X PBS solution was used to dilute all 
the samples to their final concentration prior to each run. The RRE RNA sample was heated 
for 1 minute at 95 °C and immediately placed on ice and cooled for 5 minutes before 
loading onto the sensor.  In order to ensure the RNA integrity in the binding assays, the 



















The RNA secondary structure figures were generated using mfold v.3.2 an RNA secondary 
structure prediction program, along with RnaViz v.2 software for producing RNA secondary 











2.6 Results and Discussion 
 
2.6.1 Production and Purification of RRE 
 
In-vitro transcription with T7 polymerase along with the constructed template (top strand + 
bottom strand) was used to synthesize the 30 bp RRE RNA. The success of the transcription 
reaction and purification was verified using a 12% denaturing polyacrylamide gel stained 
with SYBR Green II dye, which has a higher binding affinity for RNA than DNA, and 
shows fluorescence enhancement upon binding RNA. The result of the transcription and 
purification are shown in Figure 2.5.  Lane 2 and 3 have only the DNA template loaded that 
is in total 65 bp (18 bp top strand + 47 bp bottom strand). The polyacrylamide gel contains 
urea as a denaturant that causes the template DNA to separate into single-strands. This is 
why only the bottom strand (47 bp) is visible on the gel and the top strand (18 bp) fragment 
has run off the gel with abortion products and free nucleotides. The lanes 6 and 7 show 
unpurified 50 μL transcription reactions producing the correct size RNA. The abortion 
products and nucleotides have run off, although some are still present and seen as a streak 
down the gel. Samples of the smaller transcription reaction were kept to run as comparisons 
with the purified sample. RRE RNA was purified by UV-shadowing and cutting out the 
correct band corresponding to the RNA, followed by a crush and soak and ethanol 
precipitation to obtain the purified RNA. Lane 9 of the polyacrylamide gels shows the 
successfully purified RRE RNA obtained from a 3 mL transcription reaction, with no 





Figure 2.5- Transcription and Purification of the RRE RNA.  
 12% denaturing polyacrylamide gel stained with SYBR Green II  
showing the result of the transcription reaction and the success 
 of the purification. 
 
2.6.2 Purification of Rev peptide Crude Synthesis  
 
Crude synthesis of the Rev peptide obtained from CanPeptide Inc. was purified by RP-
HPLC to remove peptidic by-products. The crude peptide was dissolved in 10% acetonitrile 
before loading on a C18 column that separates molecules based on their hydrophobicity, 
with the most hydrophobic molecules eluting last.  The elution was done with a linear 
gradient from 10% to 60% of solvent B. The elution profile of the crude synthesis of the Rev 







Figure 2.6- Purification of the Rev peptide by RP-HPLC.  
The gray area under the peak corresponds to the collected fraction containing 
 the Rev peptide. The elution process shown was monitored at 220 nm.  
 
 
The eluted fraction was further characterized by positive ion mode ESI-MS. The molecular 
mass of the Rev peptide obtained through MS was in agreement with the expected molecular 
mass of 2993 Da (Figure 2.7). The obtained molecular mass of 2992 Da reflects the loss of a 
hydrogen atom that occurred during MS; however it still confirms that the full-length Rev 




Figure 2.7- Positive ion mode ESI-MS of the purified Rev fraction.  
The 2992 Da major peak belongs to the Rev peptide and differs by a hydrogen  
atom from the calculated mass of 2993 Da.    
 
 
2.6.3 Biotinylation of the Rev peptide  
 
The biotinylation reactions can be used to label proteins with a biotin moiety by exploiting 
NHS ester and primary amine chemistry. Primary amines react with NHS ester to form 
stable amide bonds. The reaction only works with amines in their non-protonated form. The 
reaction can be made selective by controlling the pH, thus affecting which amine groups (N-
terminal, lysine side-chain) are predominantly reacting. The biotinylation reaction was 
performed with a 1:5 molar ratio of the Rev peptide to biotin N-hydroxysuccinimide ester 
(BNHS) (Figure 2.8). The labeling reactions were allowed to go for 30 minutes and 1 hour 
before stopping. It was found that the labeling reaction was rapid for the Rev peptide; as a 
result longer reaction times were not tested. After the reaction was stopped with 1% TFA, a 
5 μL aliquot was removed to be analyzed by MS. MS was performed to determine 









Figure 2.9- Mass spectrum of biotin labeling reactions prior to purification.  




The purification of the biotinylation reaction was carried out as the correct mass was visible 
in the mass spectrum for the labeled Rev peptide. The labeling reactions were purified by 
RP-HPLC on a C18 column. To the 30 min and the 1 hour reaction 10% acetonitrile was 
added before loading the column, followed by elution using a linear gradient from 10% to 
60% of solvent B. The RP-HPLC elution profiles for the 30 minute and 1 hour labeling 




Figure 2.10- RP-HPLC elution profiles of 30 min. and 1 hr. Rev Biotin labeling reactions.  
(A) 30 min. labeling reaction with two eluting fractions at ~16 and 19 min.  
(B) 1 hr. labeling reaction with two eluting fractions at ~17 and 19min. 
 
 
The elution profiles for the two reaction times are similar with the minor difference being 
the slight variation in elution times. The amount of unlabeled peptide is also greater in the 
30 minute reaction compared to the 1 hour reaction time. The two peaks in the 
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chromatograms have both been characterized by MS (Figure 2.11). The first peak in the 30 
minute reaction eluting approximately at 16 minutes corresponds to the unlabeled peptide 
(2993 Da) with some labeled product present. The second peak eluting at approximately 19 
minutes is the N-terminally labeled Rev peptide with a mass of 3219 Da. MS analysis of the 
1 hour reaction chromatogram peaks were found to be analogous to those from the shorter 
30 minute reaction time. Labeling and purification of the N-terminally labeled Rev peptide 




Figure 2.11- Mass spectrum of the 30 min. labeling reaction identifying the collected fractions.  
(A) Peak fraction eluting at 16 min., major peak (2992 Da) corresponds to unlabeled Rev peptide.  
 (B) Peak fraction eluting at 19 min., major peak (3218 Da) indicates N-terminally labeled Rev peptide.  
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2.6.4 dotLab Binding Assay 
 
The Rev-RRE system was chosen to test the potential use of the dotLab system in 
characterizing RNA-protein interactions. In order to study the specific binding of a molecule 
to its binding partner with this system it is required that one of the components be 
immobilized on the sensor surface.  
 
In initial binding studies with the Rev-RRE interaction performed on the dotLab system we 
used the amine reactive sensors. The sensors surface contained carboxyl groups, which when 
activated with carbodiimide chemistry can couple primary amines of proteins to the surface 
through amide bond formation. The advantage of using these sensors is that small amounts 
of protein are required for the coupling reaction. Coupling of the Rev peptide to the amine 
surface at different concentrations (10 μg/mL and 30 μg/mL) was explored. The reaction 
carried out in an amine free buffer system to prevent other molecules with a free amine 
group from binding and competing with the peptide. A 6.5 pH buffer was used to promote 
the binding to N-terminus of the Rev peptide. The coupling of the Rev peptide did not 
produce big enough change on the sensor surface and was not detected. Subsequent addition 
of the RRE after the coupling of Rev did not show any changes in the diffractive index to 
indicate binding (Figure A1.1). This may have several reasons: 
 
 The Rev peptide may lay flat across the surface upon binding that it does not 
produce the necessary height change to produce a signal.  
 Immobilizing the Rev peptide through the N-terminus in close proximity to its RNA 
binding site may impair its ability to bind the RRE.  
 Steric hindrance can also block the binding sites of neighboring molecules due to the 
high concentration of immobilized molecules (Rev).  
 
Increasing the distance of the Rev peptide from the sensor surface should allow for better 
detection of surface binding and aid it in binding the RRE RNA.       
 
The avidin coated sensors utilize the high affinity between biotin and avidin to immobilize 
molecules of interest to the sensor surface. A single avidin is able to bind up to four biotin 
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molecules and can act as a signal enhancer; this however is affected by the technique used to 
immobilize the biotin to the sensor surface (42). The biotinylated Rev peptide contains a 




Figure 2.12- Avidin sensor binding depiction of Bt-Rev-RRE. 
 
  
The avidin sensor binding assays performed with the Biotin labeled Rev and the RRE 
counterpart are summarized in Table 2.1. The first binding assay involved a basic method 
used by Axela to bind large antigen/antibody molecules. There was a large increase in the 
diffractive index upon binding of the biotinylated Rev peptide (Bt-Rev), but no increase was 
observed for the binding of the RRE. Increasing the RRE incubation period and the 
concentration mixed over the sensor was unsuccessful at producing visible binding (Figure 
2.13). Lower Bt-Rev concentrations and incubation times were investigated, as surface 
crowding and steric hindrance were believed to be preventing RRE binding. The RRE RNA 
was heated at 95 °C and quickly cooled on ice to minimize formation of duplex and to 
promote hairpin structure formation. A 30 second incubation of Bt-Rev (3 μg/mL) along 
with a 5 minute incubation with previously heated RRE RNA (95 °C) produced a change in 





Figure 2.13- Binding assay performed with high concentration of Bt-Rev-RRE. 





Figure 2.14- Binding of RRE to surface immobilized Rev monitored by change in the DI over time.  
The variables changed that led to observing RRE binding are outlined in Table 2.1 under assay number 5.   
 
In order to determine if indeed crowding at the surface was interfering with RRE binding or 
if it was the RNA secondary structures was examined by increasing the Bt-Rev incubation 
period. This yielded no binding of RRE. If RNA secondary structures were responsible for 
observing no binding, then heating the RNA at higher temperature would have resolved this 
possibility. The reagent flow rates and incubation times were changed to attempt to increase 
the change in the diffractive index for Bt-Rev, thereby increasing the RRE signal as well. 
Binding was observed for RRE although the change in surface height was lower than 
previously obtained (Figure 2.15). These results show that high concentration of 
immobilized Bt-Rev at the sensor surface hinders the binding of the RRE RNA. The binding 
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of RRE to Bt-Rev has only been observed when the diffractive index change for the binding 
of Bt-Rev is less than 1 DI. In Figure 2.14, the jump in DI during the washing step 
(indicated by the arrow) after Bt-Rev incubation is believed to be the peptide that was stuck 
to the fluidic tubing and has come off in the wash. The negatively charged sensor surface 
could be contributing to the difficulty of immobilizing the Rev peptide. The Rev peptide 
contains many positively charged arginine groups that may interact with the negatively 
charged sensor surface and cause the peptide to be in an orientation where it cannot bind to 
the RRE. The addition of a BSA blocking step may minimize surface interactions with the 
sensor surface and the fluidic tubing. Due to the large size of BSA it could also promote 
crowding of the peptide. The Rev peptide can be labeled with Biotin-X-X-NHS that has a 
14 atom spacer region and would provide additional height on the sensor surface and may 
promote more favorable binding interactions. Therefore, it seems that the dotLab system is 
sensitive enough to detect the binding interaction of a small 23 amino acid peptide and a 30 




Figure 2.15- Monitoring the DI change upon binding of the RRE with longer incubation times.  
 The variables changed are found in Table 2.1 under assay 7.  A higher surface area concentration of Rev did 






















1 60 2:00 50 3:00  
2 60 0:30 80 5:00  
3 10 0:30 50 5:00 RRE heated at 65 °C 
4 5 0:30 50 5:00  
5 3 0:30 50 5:00 RRE heated at 95 °C 
6 3 1:20 50 5:00  
7 3 0:50 50 5:30 Changed flow rates 
8 3 0:50 50 5:30 Changed flow rates 
9 3 0:30 50 5:30 Changed flow rates 

























Flock House virus (FHV) was discovered on the North Island of New Zealand, and was 
isolated from the New Zealand grass grub Costelytra zealandica (White beetle) (43). The 
grubs were alive when found, but it appeared that the virus hindered their development. 
FHV was shown to have a cytopathic effect (CPE) on Drosophila melanogaster cells and 
caused characteristic cell clumping, although complete lysis of the cells was not observed. 
The CPE and the physicochemical properties indicated that FHV is a unique new emerging 
insect virus belonging to the Alphanodavirus genus in the Nodaviridae family. FHV is able to 
replicate in several insect species, plants and yeast; no CPE effects were observed in 
mammalian cells and hence it is not considered a human pathogen (43, 44).  
 
FHV is a nonenveloped positive single stranded ((+) ssRNA) virus which contains a bipartite 
genome. The virus replicates in the cytoplasm of infected cells. The genome is made up of 
two 5’ m7G-capped, nonpolyadenylated RNA’s (RNA1 and RNA2) which are both packaged 
into a single virion (45, 46). RNA1 (3.1kb) encodes protein A (112 kDa), the RNA-
dependent RNA polymerase (Rd-RP) found on the outer mitochondrial membrane of 
infected cells (47). RNA2 (1.4kb) encodes protein alpha (43kDa), a capsid precursor protein 
(Figure 1). Protein A has been shown to play a role in recruiting RNA1 to the RNA 
replication site (47). RNA1 also gives rise to a subgenomic RNA3 species, located near the 
3’- terminal end of RNA1 and consisting of 387 nucleotides. RNA3 encodes protein B2 (10 
kDa) which plays an important role in countering the RNAi defensive mechanism of the 
host (48). Protein alpha along with RNA 1 and RNA2 initially assemble into a noninfectious 
precursor particle called a provirion. The provirion matures and develops infectivity by 
spontaneous cleavage of the 407 amino acid protein alpha between the residues Asn 363 and 






Figure 3.1- Formation of Flock House virus (see text for details). 
 
 
3.2 Flock House virus Structure 
 
Until recently, the structural study of (+) ssRNA insect viruses was difficult due to the need 
for milligram amounts of intact virus for crystallization (51).  Many viral protein capsids 
have icosahedral symmetry, since it is the most efficient way to obtain a symmetrical shell 
with a maximum internal volume using asymmetric proteins (1, 9). The smallest number of 
identical protein subunits needed to construct the icosahedral capsid is 60 (1). These 
subunits are positioned in such a way that they are interconnected through the two-, three- 
and five-fold rotational axes that denote the icosahedral symmetry (1). Most viruses have 
capsids that are comprised of more than 60 subunits and, in order to understand how the 
icosahedral symmetry is maintained, one needs to look at the concept of quasi-equivalence 
by Caspar and Klug (51).   
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The quasi-equivalence theory states that each protein subunit that makes up a larger capsid 
consisting of more than 60 subunits is found in different structural environments with 
similar bonding properties (1, 52). Facets are composed of protein subunits found in 
different environments that make up the new asymmetric unit (1). The triangulation 
number (T) of a viral capsid describes the number of protein subunits needed to form the 
asymmetric unit that make up the capsid (1). The combination of the smaller triangular 
asymmetric units (facets) enables the capsid to retain its icosahedral symmetry.     
 
The FHV capsid consists of 180 protein subunits, which give rise to 60 triangular facets and 
a capsid icosahedral symmetry of T=3 (180/60=3) (Figure 2a) (53). The 60 triangular units 
are composed of three identical protein subunits (A, B and C), which consist of an eight-
stranded antiparallel β sandwich that is conserved among Nodaviruses. It should be noted 
that although there is structural conservation, the amino acid sequence is not conserved 
among the different species (53). The 3.0Å crystal structure of FHV reveals an RNA A-type 
duplex forming only at the two-fold axis of symmetry (53). The RNA duplex is ordered only 
between two C subunits of opposing orientation (C- C2) (Figure 2a). The RNA sugar 
phosphate backbone interacts with the subunits through electrostatic and van der Waal 
forces (53). The N-terminus of all three identical protein capsid subunits contains lysine and 
arginine residues and inserts into the major groove of the RNA duplex to help neutralize the 
negative charge of the RNA backbone (53, 54). RNA’s role is to prevent the bending of the 
two subunits and form a flat contact (53). The 10 ordered base pairs make up 20 % of the 
packaged genome of RNA found at each of the two-fold axes (53). The γ –peptide  produced 
as a result of maturation cleavage of the provirion is located inside the capsid interior as an 
alpha helix (53). The γC and γB helices of the C and B capsid protein subunits interact with 
the ordered RNA duplex (52). The γA helix does not interact directly with the RNA duplex 





Figure 3.2-Flock House virus structure and RNA-protein subunit interaction.  
(A) Capsid structure of FHV with T=3 symmetry. Three identical protein subunits make up the larger facet (A, 
B and C). The two, three and five fold axes are distinguished by an oval, triangle and pentagon, respectively. 
The dsRNA lies between the C-C2 subunits. (B) The tertiary structure of the C subunit of FHV. Residues 1-54 
of the N- terminus are disordered in the electron density; as well as the C-terminus residues 382-407. The 
maturation cleavage product the γ –peptide is shown as an orange alpha helix. A portion of dsRNA is shown as 
a red ribbon interaction with a portion of the N-terminus. (PDB ID# 2Q25) 
 
 
3.3 Method of Cell Entry 
 
The cell puts up quite a challenge for viruses attempting to release their genetic information 
into it, putting up complex barriers which the virus must overcome. These barriers consist of 
the plasma membrane as well as many intracellular membranes (55). The last membrane the 
virus must penetrate in order to begin its life cycle and form new progeny is referred to as the 
limiting membrane (55). The exact method of delivery has not been as well determined for 
nonenveloped viruses as it has for enveloped viruses, which are known to be able to fuse their 
viral membrane with the cell membrane, allowing them to penetrate the cell (55). 
Nonenveloped viruses have developed different methods of delivering their genome into the 
target cells as they do not have a surrounding lipid bilayer. The capsid of nonenveloped 
viruses must be sturdy enough to handle the harsh environment extremes (pH, ionic 
strength, temperature and proteases) until it reaches its limiting membrane (56). The viral 
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capsid must be able to react only with the appropriate cellular factors that will result in a 
conformational change and allow it to interact with the limiting membrane. The stability 
and conformational change of the viral capsid are believed to be key attributes in the 
assembly of the virion. During assembly, the viral capsid proteins fold into a provirion 
structure. Cleavage follows. The formation of a precursor structure gives the possibility that 
the lowest energy states differ between precursor and product. The formation of the 
provirion then traps the virus in a metastable state, and the lowest energy state of the mature 
virion is blocked due to an energy barrier (56). Binding to a host receptor then triggers the 
lowering of the activational energy needed to reach the lowest energy state for the mature 
virion and hydrophobic residues required for membrane attachment are displayed on the 
viral capsid.  
 
Infection of host cells by nonenveloped viruses follows a four step process: 1) the movement 
of the virus to the site of entry; 2) a conformational change induced by cellular factors 
(receptors, low pH, proteases or chaperones) that release a viral protein (VP) or make a 
portion of the capsid hydrophobic; both in turn are responsible for interacting with the 
membrane; 3) the binding of the hydrophobic residue or the VP to the limiting membrane 
of the host; and 4) the disruption of the lipid bilayer to transport the viral particle or the 
genome across the membrane (55). 
 
The cell entry pathway for FHV has not been fully determined, but current research suggests 
the pathway is similar to that of other (+) ssRNA viruses, more specifically to the poliovirus, 
a member of the Picoronavirus family. The poliovirus receptor (Pvr) located on the plasma 
membrane has been found to induce an irreversible conformation change in the viral particle 
(55). This change initiates the penetration process through the exposure of VP 4 and the N-
terminus of VP 1 (55, 56). VP 1 and 4 are able to insert and bind the plasma membrane 
(55). This binding causes the integrity of the membrane to diminish by forming a channel 
through which the viral genome may be injected into the cell (55). Viral particle breathing 
occurs at physiological temperatures. It is a process whereby temporary, completely reversible 
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exposure of viral proteins (VP 1 and 4 from poliovirus) required for membrane attachment 
are displayed on the capsid surface (56). The breathing in the poliovirus shows the dynamic 
nature of the capsid and alludes to the irreversible change which the particle will undergo in 
the presence of a receptor (56). Particle breathing was also found to occur in the FHV capsid 
(57). The poliovirus formed distinct particles that acted as intermediaries during cell entry 
when the virus was subjected to a binding assay of Drosophila cells (58). The particles are 
formed once the virion has dissociated from the membrane receptor. The eluted poliovirus 
particles were found to have an altered capsid structure and different physicochemical 
properties due to the absence of the VP4 subunit (58). Specifically, those poliovirus particles 
retrieved from the binding assay were unable to rebind to the Pvr (58). FHV likewise formed 
distinct intermediate particles in the same way as poliovirus does, with a portion of their γ- 
peptide missing (58). The FHV particles identified in the binding assay may represent an 
intermediate stage in the cell entry pathway while the virus is adhering to the membrane 
(58).  
 
A common feature among all Nodaviruses is the cleavage of the provirion capsid proteins to 
produce an infectious viral particle (59). FHV undergoes this cleavage reaction to produce 
the major capsid protein subunit β and the 44 amino acid residue peptide γ (49). The γ-
peptide is located inside the capsid after the cleavage reaction and has shown the ability to 
integrate into the lipid bi-layer (60). The first 21 residues of the N-terminus of the γ-peptide 
partition into the lipid bilayer and increase membrane permeability, as observed with 
fluorophore release from liposomes (Figure 3) (61, 62). The N-terminal region has a 
hydrophobic nature, with a stretch of amino acids with short side chains, a common feature 
of fusion peptides in enveloped viruses (63).  Measurements of membrane binding energy for 
the N-terminal portion of the γ- peptide revealed that the energy is analogous to that of 
natural membrane binding toxins and antibacterials (63). The high affinity of the γ-peptide 
to the membrane supports its role in membrane binding and transmembrane passage of viral 
RNA (63). The C-terminal of the γ-peptide is involved in viral RNA recognition and 
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packaging (59). As previously mentioned, only the γB and γC helices are in direct contact 
with the RNA duplex; the γA helix contacts the RNA only through its carboxyl terminus 
(52). The γA helices form pentameric bundles at the five-fold axis of symmetry through the 
interactions of their hydrophilic sides. The γA helices form a potential channel with a 








Figure 3.3- Helical wheel representation of the first 21 residues of the γ- peptide. 
 
 
The current proposed mechanism for the FHV interaction with the membrane or upon 
binding a receptor is that the subunits along the five-fold axis become destabilized, which 
allows the γA pentameric bundle to surface. The surfacing of the pentameric bundle also pulls 
the RNA along due to the C terminus interactions.  Once the γA helix reaches the 
membrane, further interaction occurs with initiation of the invagination process or creation 
of a channel for injecting the viral RNA. Poliovirus showed the release of its VP1 subunits 
upon heating; the same amino terminus was exposed during binding. The same approach 






















pentameric axis regions (52). Interestingly only a single protrusion was observed for the FHV 
capsid, which awaits characterization. 
 
3.4 Eluding the Host Defenses 
 
Many plants and insects have developed silencing pathways as a means to combat viral 
infections. The RNA interference (RNAi) pathway utilizes the RNase III enzyme (Dicer) 
that cleaves dsRNA into small interfering RNAs (siRNA) (48). The lengths of the siRNAs 
are between 19-21 base pairs (bp) and also contain 5’phosphates and 3’-two nucleotide 
overhangs (48).  The siRNAs are incorporated into the RNA-induced silencing complex 
(RISC), which is then guided to degrade single stranded RNA molecules (48).  The RNAi 
pathway is not only used in the case of viral infections. The ability of Dicer to cleave RNA 
that contains stem loop structures and generate micro RNAs was shown to have implications 
in the growth and development of cells (48). 
 
FHV encodes an RNAi suppressor protein, B2, a subgenomic RNA expressed from the 3’ 
end of RNA1. The level of B2 expression is highest upon infection and during the 
replication stage of the virus (64). A B2 monomer contains three alpha helices, which 
combine with another monomer to form a four-helix bundle through antiparallel association 
(48). This B2 dimer binds the dsRNA by recognizing two adjacent minor grooves and 
inserting itself into the major groove where it interacts with the ribose-phosphate backbone. 
In a cleavage assay, the addition of B2 completely inhibited the cleavage of a 35 bp dsRNA 
fragment by Dicer. The B2 protein was also modeled on longer dsRNAs, which suggests that 
it may prevent the silencing pathway at two key steps. By binding long dsRNA and siRNAs, 
B2 protein can prevent Dicer from cleaving the viral genome and prohibits the incorporation 
of siRNAs into the RISC. Transgenic Drosophila melanogaster, made to express viral RNA1 
and RNA2 but not RNA3 (required for B2 production), showed significantly reduced viral 
replication and overall production (64). Elimination of B2 expression showed that B2 is 
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required for viral infection. B2 as a means to prevent RNA silencing has been used by FHV 
to infect multiple hosts: plants, insects and worms.  
 
3.5 Formation of Progeny 
 
3.5.1 RNA Translation 
 
FHV has a (+) ssRNA genome which has the same polarity as mRNA. This feature of 
positive stranded viruses makes them extremely infectious, since once the penetration of the 
cellular membrane has occurred, the virus may begin translating the viral genome and 
replicating shortly after (65). Translation of FHV genome occurs before replication, as 
RNA1 encodes an Rd-RP required for replication. A recombinant baculovirus system was 
used to show that only coat proteins translated from replicating RNA packaged RNA1 and 
RNA2 (66). Non-replicating RNA1 and RNA2 transcripts produced coat proteins which 
packaged cellular RNA. Uncoupling protein synthesis from RNA replication showed that the 
RNA2 can be packaged without the presence of RNA1 only if the capsid protein is translated 
from a replication-competent RNA2 (66). The discrimination of differentially translated 
coat proteins supports the notion that coat protein translation takes place in specific cellular 
compartments (67). The FHV coat protein is highly basic and it was observed that the coat 
protein can assemble around cellular RNA with similar efficiency as with viral RNA. The use 
of cellular compartments by viruses would confine the coat proteins to be in close proximity 
of the RNA replication area where there is a high concentration of viral RNAs (67).   
 
 The mechanism used by FHV for translating its nonpolyadenylated genomic RNAs 
is still unknown. There are different factors which must be initiated in order for translation 
to occur, and (+) ssRNA viruses seem to utilize an unknown approach when regulating their 
own translational machinery (1). Internal ribosome entry sites (IRES) have been shown to 
exist in many (+) ssRNA viruses; poliovirus was found to contain a region which promotes 
internal ribosome entry.  The region located in the 5’ untranslated regions of the RNA was 
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found to have many secondary and tertiary structures that promote the binding of the 
ribosomal subunit to the IRES start codon. IRES(s) have not been identified for FHV. The 
3’ untranslated region (UTR) found in positive stranded RNA viruses were found to contain 
structures which resemble tRNA-like elements (68). In eukaryotes translation is believed to 
occur in a closed loop formation with the 5’ and 3’ ends being brought close together. The 
key interaction is between the 3’ poly A tail and the translation initiation factor 4E which 
binds the 5’ cap (68). The effect of the poly A tail is to increase translational efficiency and 
provide stability to the RNA. The 3’ UTR is thought to play a similar role in positive strand 
RNA viruses as the poly A tail; it was seen to enhance protein expression such as in the plant 
virus Alfalfa mosaic virus (AMV). The translational initiation factors used by FHV are not 
known, although it can be seen that coat protein translation is highly regulated and 
dependent on viral RNA replication.  
 
 3.5.2 RNA Replication 
 
FHV forms a replication complex that is conserved among many (+)RNA virus families (69). 
RNA replication in FHV takes place on the outer mitochondrial membrane. Protein A, 
which is the Rd-RP, is the only protein required for replication. The N-terminus of protein 
A contains sequences for transport into the mitochondrial membrane and for insertion. 
Protein A acts as an integral membrane protein with the N-terminus inserted into the 
intermembrane space or the matrix and the C-terminus faces the cytoplasm. The movement 
of protein A to the mitochondrial membrane is independent of RNA replication. Electron 
microscopy revealed the formation approximately 50 nm membranous vesicles, located in 
the intermembrane space and bound to the outer mitochondrial membrane (Figure 5) (70). 
The FHV vesicle contains an opening of approximately 10 nm that allows for the flow of 
replication material to the cytoplasm (70). On average, each vesicle contains about 100 
protein A molecules which associate with the mitochondrial membrane and with one 
another (70, 71). Protein A recruits RNA1 before RNA negative strand synthesis occurs, to 
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the mitochondrial membrane where the RNA replication complex will form (47). 
Recruitment of RNA1 to the replication site involves a cis-acting RNA element located 
between nt 68-205. In this region two stem loop structures exist, similar in sequence, and are 
essential for RNA1 recruitment (72). FHV uses cellular components to help form the 
replication complexes. It was demonstrated that by inhibiting the cell chaperone protein 
Hsp90 the synthesis of protein A was suppressed (73). The use of chaperone proteins to 
control distinct steps in viral RNA replication is found in other (+)RNA viruses, as are 





Figure 3.4- The organization of the FHV vesicle replication complex. 
Protein A is represented by green circles showing the N-terminus being embedded in the membrane and the C-
terminus exposed to the cytoplasm. A 10 nm opening connects the replication complex with the cytoplasm.  
 
 
FHV displays a high degree of control in the replication of RNA1 and RNA2. Subgenomic 
RNA3 plays an important role in the replication process acting as a trans-activator for the 
replication of RNA2 (74). The exact mechanism of the transactivation has not been 
determined, but a signal involved has been located on the 3’ end of RNA2 (75). The 
activation of RNA2 suppresses the transcription of RNA3 (76). It is believed that the 
regulation of RNA3 directs the replication of RNA1 and RNA2 (74). The mechanism used 
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by RNA1 to synthesize RNA3 has not been identified, although it is believed that premature 
termination is responsible for the synthesis of RNA3 (77). Premature termination is used by 
many plant viruses such as the Tomato bushy stunt virus and Red clover necrotic mosaic 
virus to regulate the subgenomic RNA expressions (78). Premature translation occurs with 
the synthesis of the negative sense RNA1 to end early, thereby creating the negative sense 
RNA3, which can then be use for the synthesis of the positive sense of RNA3 (79). A long 
distance base pairing interaction was observed in RNA1 that is required for RNA3 synthesis, 
similar to the interactions occurring in plant viruses; leading to the belief that long distance 
interaction in FHV may promote the synthesis of negative sense RNA1 to end early (77, 78). 
When RNA1 was supplied with a functional 5’ replication element, the 108 nucleotide 
sequence at its 3’ end was all that was required for its replication (75). The same sequence is 
found at the 3’ end of the subgenomic RNA3 and may also act as replication element (75). 
Studies with RNA2 revealed that a minimum of 3 nucleotides are required at the 5’ end for 
efficient replication (80). If the same 5’ end requirements are needed for RNA1 replication, 
then RNA3 would contain the same 3 nucleotides required for replication (79). This concept 
was tested and was shown that RNA3 could be produced from RNA1 transcription and 
independent replication (79).  
 
3.5.3 RNA Packaging 
 
FHV exploits the plasticity of RNA to aid it in the packaging of the viral RNA genome. It 
was seen that packaged RNA takes on a dodecahedral structure within the virion. This is 
largely due to the plasticity of the RNA and its capability to form dynamic secondary 
structures (81). 10 bp regions located at each of the 2 fold axis appear visible in the X-ray 
structures. It is not known however which segments of the genome assume these positions. 
Through competition experiments it was observed that FHV preferably packages viral RNA 
over the cellular RNA.  After the deletion of coat protein segments which recognize viral 
RNA, cellular RNA was packaged and adopted an indistinguishable dodecahedral structure 
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as the viral RNA (81). This also implies that it is not the RNA sequence which controls the 
organization inside the virion but the coat protein (54, 81). It was established that viral RNA 
does not fold spontaneously prior to packaging, since randomly packaged cellular RNA 
conforms to the same dodecahedron structure independent of its sequence and length. The 
possibility of packaging to occur during RNA replication has also been ruled out with pulse-
chase experiments, showing that viral RNA is packaged with a 30 min delay (82). A likely 
explanation is that the capsid proteins act as chaperones as seen for the HIV nucleocapsid 
protein and the hepatitis delta virus antigen. The capsid proteins bind viral RNA stabilizing 
less favorable structures thereby facilitating proper assembly to occur (54).   
 
FHV specific encapsidation sequences must be present on viral RNA and are used by capsid 
proteins to preferentially bind viral RNA with higher affinity than cellular RNA (54). 
Deletions and mutation studies on the C-terminus of FHV protein alpha, which becomes γ-
peptide in the mature virion, showed complete loss of FHV genome recognition and resulted 
in the packaging of cellular RNA (59). The loss of viral RNA packaging was due to the 
deletion of the 44 residues of the C-terminus or single site amino acid substitutions of 
phenylalanines at positions 402, 405 and 407 (59). Deletion of residues 2-31 on the N-
terminus of protein alpha yielded particles which differ in capsid structure and RNA content 
(83). The recognition of RNA2 was affected as the virions showed a decreased amount of 
RNA2 present inside (83). The region 35-49 of the N-terminus of the coat protein in FHV 
contains the arginine rich RNA binding motif (ARM) which is highly conserved among 
plant and non-plant viruses such as Brome mosaic virus and HIV (84). The substitution in 
the 32-50 region (ARM) of the N-terminus of all arginine residues to alanines resulted in the 
loss of RNA1 packaging specificity in FHV, and the viral particles contained only RNA2 
(85). The highly positive nature of the ARM region is required for packaging, as was 
concluded with a substituted lysine mutant that retained packaging function. Fully 
functional viruses were also assembled when the ARM region of FHV was replaced by HIV-
1 Rev protein, suggesting the importance of the region for recruiting viral RNA’s to 
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replication sites. The recombinant baculovirus system showed that RNA1 was not required 
for virion assembly; when the cDNA of RNA2 was provided then the viral particles still 
formed mature FHV virions undistinguishable from authentic FHV virions (86).  
 
Specific encapsidation sequences that promote the binding of the capsid protein to the viral 
RNA with high affinity as opposed to random cellular RNA have been identified for a 
number of viruses. The MS2 bacteriophage has a (+) ssRNA genome consisting of a single 
viral RNA. An RNA packaging signal sequence has been located on the MS2 phage, and it is 
a hairpin structure containing 19 nucleotides located at the 5’ end of the replicase gene (87, 
88). The coat protein dimer interacts with the hairpin loop and the unpaired adenine 
nucleotide in the hairpin (89). AMV packaging signal sequences have also been identified. 
The signal sequence is found at the 3’UTR in all AMV RNAs and is made up of 39 
nucleotides (90, 91). The coat protein interacts with the AUGC repeats found at the bottom 
of the stem structures (92). The encapsidation sequences for viral RNAs are found at 
different positions throughout the genome and take on specific secondary structures which 





Figure 3.5- Capsid protein recognition sequences for viral RNAs of MS2 bacteriophage (A) and AMV (B). 
 
 
Flock House virus has the smallest genome among RNA viruses (44). This feature and its 
wide host range make it an ideal choice for studying viral entry, replication and assembly. 
FHV being a (+) ssRNA icosahedral virus is part of a group of viruses to which many known 
 42
human pathogens belong to such as poliovirus, hepatitis A virus, human rhinoviruses, 
Norwalk group of viruses, and flaviviruses (54). Studying the mechanism of FHV assembly 
can aid in development of potential therapeutic agents which inhibit viral RNA packaging 
that can also be applied to other icosahedral (+) ssRNA viruses. The study of viral RNA 
packaging can also be applied to other RNA viruses (ex. influenza), as it is common among 
viruses to have many analogous mechanisms.         
 
3.6 Research Objective 
 
The capsid protein regions thought to interact with RNA1 and RNA2 during viral genome 
packaging have been identified by Dr. A. Schneemann. The N-terminal regions 1-31 and 
32-50 of coat protein alpha are required for recognition of RNA2 and RNA1 respectively. 
The aim of this study is to identify the specific RNA and the sequence that interacts with the 
FHV coat protein (59, 83). The N-terminal regions identified as viral RNA packaging 
requirements will be used as targets to select for the RNA sequences with the dotLab system. 
The regions 1-30 and 31-58 from the N-terminus of protein alpha will construct the two 
selection targets. The full RNA1 and RNA2 sequences used in the binding selection can be 
















3.7 Materials and Methods 
 
3.7.1 Minimization of RNase Contamination 
 
A number of precautions were taken to minimize RNase contamination during RNA 
production. Fresh gloves were worn at all times. All preparation areas were wiped with 
RNase AWAYTM. All buffers were made from nuclease-free Milli-Q water and autoclaved. 
All the labware used was wrapped in aluminum foil and autoclaved at 121 °C; prior to use it 
was washed with RNase AWAYTM followed by rinsing 3X with nuclease-free Milli-Q water. 
All plastic-ware utilized was RNase free certified by their respective manufacturers. During 
RNA synthesis reactions RNase inhibitor was added. 
 
3.7.2 FHV Peptide 
 
The FHV1 peptide containing one of the RNA selection target regions specifically amino 
acid residues 1-30 was ordered from Bachem. The peptide was ordered with a biotin moiety 
attached at the N-terminus and two additional alanine residues were added to provide a 
short linker region (Biotin-AAVNNNRPRRQRAQRVVVTTTQTAPVPQQNV).  
 
3.7.3 Preparation of Plasmid DNA  
 
Flock House virus RNA1 (3.1 kb) and RNA2 (1.4 kb) were each cloned into pSC-B vector 
(3.5 kb) and placed into Strataclone competent cells (Stratagene) by Dr. Elaine Collins. Cells 
containing plasmids pSC-B R1 and pSC-B R2 were grown on Luria-Bertani (LB) plates 
supplemented with ampicillin (100 μg/mL).  A single isolated colony was selected from each 
LB plate and used to inoculate individual LB mediums containing ampicillin (100 μg/mL). 8 
mL of the ampicillin-LB media were inoculated and incubated overnight at 37 °C.  5 mL of 
the overnight bacteria culture was processed for each plasmid. Further plasmid DNA 
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isolation and purification was done with the Wizard Plus SV Minipreps DNA purification 
system (Promega).     
 
A 1% agarose gel containing 1.5 μL of ethidium bromide (10 mg/mL) was casted, to check if 
the plasmid DNA had been successfully purified. The gel was visualized by excitation at 365 
nm with a 560 nm emission filter on the FluoroChem FC2 imaging illuminator coupled 
with AlphaEaseFC v.6.0 software (Alpha Innotech).  
 
3.7.4 Linearization of Plasmid DNA  
 
pSC-B R1 and pSC-B R2 were linearized with HindIII (Fermentas). Completed digestion of 
the plasmids was checked on 1% agarose gel containing 1.5 μL of ethidium bromide (10 
mg/mL). Digestion reactions were cleaned up using QIAquick PCR purification kit 
(Qiagen). The concentration of the linearized plasmids was determined using the NanoDrop 
UV-Visible spectrophotometer (NanoDrop Technologies).  
 
3.7.5 Synthesis of RNA 
 
The transcription reaction mixture was setup as described in Table 3.1 for both pSC-B R1 
and pSC-B R2 plasmids.  
 
Table 3.1- Transcription reaction mixture. 
Solution Final Concentration 
Tris-HCl buffer pH 7.5 80 mM 
DTT  15 mM 
MgCl2 33 mM 
Spermidine 1 mM 
rATP, rGTP, rCTP, rUTP 3.75 mM each 
Linearized template DNA  1 μg 
RNase Inhibitor 1 unit/μL 




The T7 RNA polymerase is added and the reaction is incubated at 37 °C for 4 hours. Once 
the transcription reaction is completed 1unit/ μL RQ DNase I (Promega) is added to the 
transcription reaction to destroy the DNA template. The reaction is incubated for an 
additional 15 minutes at 37 °C.  
 
The transcription mixture was extracted with 1 volume of citrate-saturated phenol (pH 
4.7):chloroform:isoamyl alcohol (125:24:1). The mixture was briefly vortexed and 
centrifuged at top speed in a tabletop Minispin microcentrifuge (Eppendorf). The upper 
aqueous layer is transferred to a new tube and extracted once more with 1 volume of 
chloroform:isoamyl alcohol (24:1). The top aqueous phase transferred to a new tube is 
ethanol precipitated with the addition of 1/10th the volume of sodium acetate (pH 5.2) and 
2.5 volumes of cold 100% ethanol. The ethanol precipitation reaction is left at -80 °C for an 
hour or 10 minutes on dry ice; followed by centrifugation at maximum speed (4 °C). The 
pellet is washed with the total volume of the precipitation using cold 70% ethanol; followed 
by centrifugation at maximum speed (4 °C). The supernatant was removed and the 
remaining pellet is placed on dry ice for 10 min. and placed on the FreeZone Plus 4.5L 




The RNA secondary structure figures were generated using mfold v.3.2 an RNA secondary 
structure prediction program, along with RnaViz v.2 software for producing RNA secondary 
structure drawings (39-41). Peptide sequences were made using ChemBioDraw Ultra 11.0 







3.8 Results and Discussion 
 
3.8.1 Plasmid DNA Isolation and Purification 
 
After isolation and purification plasmids pSC-B R1 (6.6 kb) and pSC-B R2 (4.9 kb) were 
analyzed on a 1% agarose gel and visualized using ethidium bromide. Lambda DNA digested 
with EcoRI and HindIII was loaded onto the gel as a marker for size comparison. Figure 3.6 
contains the agarose gel of the plasmids after purification. The gel indicates that the isolated 
and purified DNA plasmids are of the correct size (lane 1 and 2). The different size bands 
that appear for the two plasmids are due to the different conformations (relaxed, nicked, 
supercoiled) that the plasmid DNA can adopt.   
 
 
Figure 3.6- Agarose gel of plasmid DNA isolation and purification.  
pSC-B R1 and pSC-B R2 are shown in lanes 1 and 2 respectively. The lambda  







3.8.2 Linearization of Plasmid DNA 
 
The linearization of pSC-B R1 and pSC-B R2 was done with the HindIII restriction 
endonuclease.  Once the plasmids were fully digested, the removal of restriction enzyme was 
required for downstream purposes. The lambda/pUC mix marker was used for size 
determination of the linearized plasmids. The fully digested and purified plasmids containing 
RNA 1 and 2 inserts are observed on the agarose gel (Figure 3.7).   
 
 
Figure 3.7- Purified linearized pSC-B R1 and pSC-B R2 plasmids.   
Lane 1 and 2 show the completely linearized pSC-B R1 and pSC-B R2 plasmids of correct size,  
confirmed by the Lambda/pUC mix marker.    
 
 
3.8.3 Gel Electrophoresis of In-vitro Transcriptions  
 
The transcription reactions were assessed by electrophoresis on the Experion system to 
determine if the full length products of RNA 1 and RNA 2 have been synthesized. The 
virtual electrophoresis gel of the FHV RNA transcription reactions contains bands of 
incorrect size in addition to the correct transcript product (Figure 3.8). The correct size of 
3.1 kb and 1.4 kb are present for FHV RNA 1 and RNA 2. There are several possibilities 
that may explain why shorter/longer transcript products are obtained along with the correct 
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full-length product. The first explanation to consider and easiest to confirm is that the size 
difference is caused by the Experion system. This may be due to an unknown interaction 
with fluorescent dye used to detect the RNA or with the components in the gel matrix. 
Using a different method to check the size of the RNA for instance a Formaldehyde or 
Glyoxal/DMSO agarose gel would determine if the problem lies with the Experion. 
 
For fragments smaller in size it is known that they are not abortion products as they are too 
large in size. T7 polymerase produces abortion products early on in the transcription 
generating products ~6-10 nucleotides in length. These smaller abortion fragments will not 
be seen on the Experion system. It is possible that the transcription reaction conditions are 
not ideal for the home-made T7 enzyme causing the early removal of the enzyme from the 
template. Lowering the reaction temperature during transcription will slow down the T7 
enzyme, and may prevent it from being displaced by any secondary structures in the 
template. The templates have been transcribed before in the lab by SP6 and T3 RNA 
polymerase and by other labs using the T7 RNA polymerase without any additional 
transcripts made. Therefore, it can be concluded that the problem is not sequence specific. 
 
The presence of longer sized transcription products is more puzzling because in general 
longer templates have more stable transcription complexes and produce a larger amount of 
the desired RNA. It has been reported with shorter templates that abortion products 
complimentary at the 3’ end to the RNA transcript can form RNA primed templates (40). 
These RNA primed templates can be extended by T7 to generate longer sized transcripts. 
With shorter templates the abortion products make up a larger percentage of the 
transcription yield increasing the probability for longer size RNA’s. The correct size RNA 




Figure 3.8- RNA electrophoresis virtual gel displaying transcription products from the transcribed linear pSC-
B R1 and pSC-B R2 templates.   
The arrow head indicates a 50bp fragment from the buffer used to standardize the sample with the RNA ladder 
(L). RNA 1 is shown in lane 1 and RNA 2 in lane 2, both transcriptions contain different length RNA’s from 

















Chapter 4: Conclusions and Future Work  
 
The aim of this study was to show the potential application of the dotLab system in 
characterizing RNA-protein interactions. The sensitivity of the system was tested with the 
well characterized Rev-RRE interaction from the HIV-1 virus.  It was shown that the Rev 
peptide can be immobilized on the sensor surface via the avidin-biotin interaction, and the 
subsequent binding of the RRE could be detected on the dotLab system. The RNA-protein 
interaction was greatly affected by the immobilization techniques and steric hindrance at 
surface of the sensor.  
 
Further research aimed at minimizing surface interactions possible with different biotin 
derivatives, in which a longer linker region is used to increase the height of the peptide and 
provide better access for the RRE RNA. Further work needs to be done to produce more 
consistent binding curves for the Rev-RRE interaction, from which kinetic data can be 
extracted and compared to existing kinetics for the Rev-RRE model. It would be interesting 
to perform preliminary binding studies with the Flock House virus using the dotLab system 
or a streptavidin paramagnetic bead pull-down assay. For this purpose production of 
sufficient amounts of full-length FHV RNA 1 and RNA 2 are required. 
 
The results of this study indicate that the dotLab system is sensitive enough for the study of 
RNA-protein interactions and could be used for characterizing novel viral RNA binding sites 
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Figure A1.2- Fluorescence spectra intensities used to compose virtual gel images.   




A2. Labeling and Purification of eNOS peptide 
 
The dotLab system was to be used to study the binding interaction between eNOS and 
Cam. The 20 residue eNOS peptide (TRKKTFKEVANAVKISASLM) was to be monitored 
binding to Cam on an amine sensor.   
 
The coupling of Cam (16.7 kDa) protein to the amine sensor surface was unsuccessful with 
no change in the diffractive index. Prior to coupling Cam to the sensor buffer exchange had 
to be performed in order to remove the amine containing buffer (Tris).  The coupling of the 
eNOS peptide to the amine sensor was attempted and no surface coupling could be detected.  
Some of the reasons that could have contributed to no detection of binding are:  
 
 The coupling reactions of Cam may have had trace amounts of free amines in the 
buffer that were not sufficiently removed by buffer exchange, thereby preventing 
coupling to the surface.      
 
 The eNOS peptide and Cam possibly did not produce a large enough change in the 
sensor surface upon coupling for detection.  
 
 Immobilization effecting the conformation of the coupled molecules and steric 
hindrance from nearby molecules could have impacted binding.   
 
It should be possible to see the coupling of either eNOS peptide or Cam to the sensor 
surface, since surface activation alone is enough to produce a detectable change. Reducing 
protein concentrations and incubation periods could enhance coupling and subsequent 
binding steps. Exploring other coupling chemistries that could be performed on the sensors 
without damaging effects by modifying the carboxyl groups could provide more effective 
means and enhance coupling reactions.  
 
It was decided that the avidin sensors may be a better initial approach because the biotin 
moiety would provide increased length from the sensor surface. The use of the avidin sensor 
would require N-terminally biotin labeled eNOS peptide. The biotinylation reaction was 
carried out in the same manner as for the Rev peptide. More caution had to be taken with 
 63
labeling eNOS due to the presence of 4 lysine residues that could be labeled as well besides 
the N-terminal amine. The buffer used for labeling was at pH 6.5; this promotes labeling of 
the N-terminal amine group. The biotinylation reaction occurs with primary amines that are 
not in their protonated form.  At pH 6.5 the amount of protonated amines will be higher for 
lysine side chain amine groups (pKa 10.5) than the N-terminal amines (pKa 9.0). The ratio 
of non-protonated amines will be higher for the N-terminal amines thus promoting labeling 
at the N-terminus. eNOS can be labeled in different amounts, with only one binding site 
labeled to all the binding sites labeled (Table A2.1).  
 
Table A2.1- Possible eNOS modifications with biotin labeling.  









The labeling reaction and purification for eNOS were performed as previously described for 
Rev in Section 2.5.5 Labeling and Purification of Rev Peptide.  The elution profile of labeled 
eNOS shows 12 separate peaks (Figure A2.1). The numbered peaks were characterized by 
positive ion mode mass spectrometry. Only early eluted peaks were identified because the N-






Figure A2.1- Elution profile of the 2 hour biotinylation reaction of eNOS.  




Mass spectrometry characterization of the individual fractions (Figures A2.2-A2.6) indicated 
that the N-terminally labeled protein could be in either 2nd or 3rd fraction. The single biotin 
labeled peptide could be the biotin located at the N-terminal or at any of the lysine residues 
in the peptide. The labeled peptide could be used on the biotin sensor to check if Cam still 
binds or digestion with a specific protease. Cleavage products could then be used to 





Figure A2.2- Mass spectrum characterization of the first fraction from the purification elution profile.  





Figure A2.3- Mass spectrum characterization of the second fraction from the purification elution profile.  
The major peak indicates the fraction contains eNOS peptide with a single biotin label. 
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Figure A2.4- Mass spectrum characterization of the third fraction from the purification elution profile.  





Figure A2.5- Mass spectrum characterization of the fourth fraction from the purification elution profile.  






Figure A2.6- Mass spectrum characterization of the fifth fraction from the purification elution profile.  
The major peak indicates the fraction contains eNOS with two biotin labels and a trace of peptide containing 
three biotin labels. 
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